Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control

BMC Public Health

Susana V Nery¹  António J Langa¹  Yuri V Sebastião¹  João E Pires¹ 

[1] CISA Project (Health Research Center in Angola), Rua Direita do Caxito, Caxito, Bengo, Angola

关键词: Epidemiological transition;    Prevalence;    Hypertension;    DSS;    Angola;   

Others  :  1162589
DOI  :  10.1186/1471-2458-13-90

 received in 2012-08-02, accepted in 2013-01-25,  发布年份 2013

【 摘 要 】

Background

Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and control of hypertension and associated factors in an adult population of Angola.

Methods

A community-based survey of 1,464 adults, following the World Health Organization's Stepwise Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension, awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database, a representative sample of subjects, stratified by sex and age (18–40 and 41–64 years old), was selected.

Results

Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the subjects aware of their condition were under pharmacological treatment, of which approximately one-third were controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be significantly (p<0.01) associated with hypertension.

Conclusions

Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the prevalence of hypertension and cardiovascular disease.

【 授权许可】

   
2013 Pires et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]World Health Organization: Global status report on noncommunicable diseases 2010. Available at: http://www.who.int/nmh/publications/ncd_report_full_en.pdf webcite
• [2]World Health Organization: Global health risks: mortality and burden of disease attributable to selected major risks 2009. Available at: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf webcite
• [3]Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, Stichele RV, Van Bortel LM: Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens 2011, 29:1243-1252.
• [4]Addo J, Smeeth L, Leon DA: Hypertension in sub-saharan Africa: a systematic review. Hypertension 2007, 50:1012-1018.
• [5]Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
• [6]Pereira M, Lunet N, Azevedo A, Barros H: Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009, 27:963-975.
• [7]World Health Organization: STEPS manual. Available at: http://www.who.int/chp/steps/manual/en/index.html webcite
• [8]Ng N, Van Minh H, Tesfaye F, Bonita R, Byass P, Stenlund H, Weinehall L, Wall S: Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition. Scand J Public Health 2006, 34:199-208.
• [9]World Health Organization: Non comunicable diseases country profiles 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241502283_eng.pdf webcite
• [10]African Development Bank, African Development Fund: ANGOLA 2011–2015 Country Strategy Paper & 2010 Country Portfolio Performance Review. Available at: http://www.afdb.org/fileadmin/uploads/afdb/Documents/Project-and-Operations/ORSB%20Angola%20CSP%202011%20-%202015%20En%20Rev%20Version%2BMemox.pdf webcite
• [11]Costa M, Rosário E, Langa A, Bendriss A: Setting up a Demographic Surveillance System in the Dande Municipality, Angola. Available at: http://www.cisacaxito.org/contents/documents/13039962813261.pdf webcite
• [12]Sousa-Figueiredo JC, Gamboa D, Pedro JM, Fancony C, Langa AJ, Soares Magalhaes RJ, Stothard JR, Nery SV: Epidemiology of malaria, schistosomiasis, geohelminths, anemia and malnutrition in the context of a demographic surveillance system in northern angola. PLoS One 2012, 7:e33189.
• [13]Instituto Nacional de Estatística: Manual de Instruções do Inquiridor 2008. Available at: http://ineangola-ibep.com/questionario_manual/manual_inquiridor_ibep.pdf webcite
• [14]World Health Organization: The STEPS Instrument and Support Materials. Available at: http://www.who.int/chp/steps/instrument/en/index.html webcite
• [15]Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG: Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit 2006, 11:165-171.
• [16]World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:1-253.
• [17]World Health Organization: Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. Available at: http://whqlibdoc.who.int/publications/2011/9789241501491_eng.pdf webcite
• [18]Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N: Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition. Hypertension 2009, 54:77-83.
• [19]Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masiuan M, Gebremichael A: The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens 2006, 20:59-65.
• [20]Guo F, He D, Zhang W: Trends in prevalence, awareness, management, and control of hypertension among united states adults, 1999 to 2010. J Am Coll Cardiol 2012, 60:599-606.
• [21]Agyemang C, Bruijnzeels MA, Owusu-Dabo E: Factors associated with hypertension awareness, treatment and control in Ghana. J Hum Hypertens 2006, 24:67-71.
• [22]Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R, Phillips RO, Plange-Rhule J, Eastwood JB: Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension 2004, 43:1017-1022.
• [23]Joshi R, Jan S, Wu Y, MacMahon S: Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol 2008, 52:1817-1825.
• [24]Mathenge W, Foster A, Kuper H: Urbanization, ethnicity and cardiovascular risk in a population in transition in Nakuru, Kenya: a population-based survey. BMC Public Health 2010, 10:569. BioMed Central Full Text
• [25]Wamala JF, Karyabakabo Z, Ndungutse D, Guwatudde D: Prevalence factors associated with hypertension in Rukungiri district, Uganda - a community-based study. Afr Health Sci 2009, 9:153-160.
• [26]Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J, Aspray TJ, Alberti KG: Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens 2000, 18:145-152.
• [27]Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V, Mbananga N: Obesity in South Africa: the South African demographic and health survey. Obes Res 2002, 10:1038-1048.
• [28]Whitworth JA: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003, 21:1983-1992.
• [29]Bovet P, Gervasoni J-P, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C, Burnier M, Paccaud F: Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens 2003, 21:509-517.